Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
US-Listed Public Company Profile built from SEC and market records · June 2026

ZIMMER BIOMET HOLDINGS, INC. (ZBH)

$97.44 -1.14% NYSE: ZBH · 15-min delayed
  • WARSAW, Indiana
  • Public · NYSE: ZBH
  • 17,000 employees
  • Founded 1927
$17.7BMarket cap
$8.2BRevenue · FY2025
$705.1MNet income
17,000Employees
ZBHNYSE
2001IPO

About ZIMMER BIOMET HOLDINGS, INC.

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$8.2B
Net income
$705.1M
Total assets
$23.1B
Market cap
$17.7B

Source: SEC EDGAR · updated Jun 7, 2026

NYSE: ZBH
$97.44 -1.14%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$79.58 $103.98

52-week range

Market cap
$17.7B
Dividend yield
0.99%
Shares outstanding
181.4M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
Aug 7, 2001

Zimmer Biomet Holdings, Inc. (ZBH) Stock Price

  • Profitable — net income of $705.1M in FY2025.
  • Trading 6% below its 52-week high.
  • Pays a dividend yielding about 0.99% annually.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

Peers & competitors

No reviews yet. Be the first to review ZIMMER BIOMET HOLDINGS, INC..

Write a review
Newsroom

News about ZIMMER BIOMET HOLDINGS, INC.

News & sentiment via Polygon.io

FAQ

Zimmer Biomet Holdings, Inc.: frequently asked questions

Is Zimmer Biomet Holdings, Inc. an American company?

Yes — Zimmer Biomet Holdings, Inc. is an American company. Zimmer Biomet Holdings, Inc. is incorporated in Delaware, United States and headquartered in Warsaw, Indiana. Its legal-entity record reports no foreign parent — the company is independently American-owned.

Where is Zimmer Biomet Holdings, Inc. incorporated?

Zimmer Biomet Holdings, Inc. is legally incorporated in Delaware, United States, according to its GLEIF legal-entity record.

Who owns Zimmer Biomet Holdings, Inc.?

Zimmer Biomet Holdings, Inc. reports no parent company in its legal-entity record — it is independently owned rather than a subsidiary.

Is Zimmer Biomet Holdings, Inc. traded on a US stock exchange?

Yes — Zimmer Biomet Holdings, Inc. trades under the ticker ZBH on the NYSE.

Where is Zimmer Biomet Holdings, Inc. headquartered?

Zimmer Biomet Holdings, Inc. is headquartered in Warsaw, Indiana, United States.

Is Zimmer Biomet Holdings, Inc. publicly traded?

Yes — Zimmer Biomet Holdings, Inc. is a publicly traded company. Its stock trades under the ticker symbol ZBH on the NYSE.

What does Zimmer Biomet Holdings, Inc. do?

Zimmer Biomet Holdings, Inc. is an American Medical Devices company in the Health & Beauty sector.

When was Zimmer Biomet Holdings, Inc. founded?

Zimmer Biomet Holdings, Inc. was founded in 1927.

Explore

Similar companies

Browse all →